Thomas J. Schuetz
Board Member
Compass Therapeutics, Inc. (CMPX)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2020-06-17–present
-
Current
2015-01-01–present
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Compass Therapeutics, Inc. (CMPX) | MD., Ph.D. Chief Executive Officer | $630,000 | $5,097,150 |
| 2024 | Compass Therapeutics, Inc. (CMPX) | M.D., Ph.D. Chief Executive Officer | $575,000 | $3,093,057 |
| 2023 | Compass Therapeutics, Inc. (CMPX) | M.D., Ph.D. Chief Executive Officer | $575,000 | $4,873,206 |
| 2022 | Compass Therapeutics, Inc. (CMPX) | M.D., Ph.D. President of Research & Development (formerly CEO) | $550,000 | $2,115,185 |
| 2021 | Compass Therapeutics, Inc. (CMPX) | M.D., Ph.D. Chief Executive Officer | $4,000 | $5,258,000 |
| 2020 | Compass Therapeutics, Inc. (CMPX) | M.D., Ph.D. Chief Executive Officer | $4,000 | $2,556,793 |
| 2019 | Compass Therapeutics, Inc. (CMPX) | M.D., Ph.D. Chief Executive Officer | $400,000 | $1,373,843 |
Recent activity
No earnings-call appearances or filed executive changes recorded yet.